List of largest biomedical companies by revenue

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

The following is a list of the top independent pharmaceutical, biotechnology and medical companies ranked by their revenue generated in (billion dollars) in the respective financial year, it does not include biotechnology companies that are now owned by, or part of, larger pharmaceutical groups.

The change is the companies relative position in this list, compared to their relative position in the prior year; i.e., an increase would be moving closer to rank 1 and vice versa. Green cells indicate years where revenue increased compared to the previous year, red cells indicate those years where there has been a decrease.

Top pharmaceutical companies with revenue over $10 billion[edit]

Rank Chg Company 2020

USD billions

2019
USD billions
2018
USD billions
2017
USD billions
2016
USD billions
2015
USD billions
2014
USD billions
2013
USD billions
2012
USD billions
2011
USD billions
1 Steady United States Johnson & Johnson
NYSEJNJ
82.6 82.06[1] 81.60[2] 76.50[3] 71.89[4] 70.10[5] 74.30[6] 71.31[7] 67.20[8] 65.00[9]
2 Increase 1 China Sinopharm
SEHK1099
66.3 60.18[10] 48.75[11] 43.63[12] 36.56[13] 32.36[14] 28.32[15] 23.61[16] 19.31[17] 14.46[18]
3 Decrease 1 Switzerland Roche
SIXROG
63.85[19] 56.86[20] 57.37[21] 50.11[22] 47.70[23] 49.86[24] 48.53[25] 47.80[26] 45.21[27]
4 Decrease 7 United States Pfizer
NYSEPFE
41.9 51.75[28] 53.60[29] 52.54[30] 52.82[31] 48.85[32] 49.61[33] 51.58[34] 58.99[35] 65.26[36]
5 Increase 1 Germany Bayer
FWBBAYN
48.02 [37] 45.06[38] 37.94[39] 25.27[40] 24.09[41] 25.47[42] 24.17[43] 24.30[44] 23.11[45]
6 Increase 1 Switzerland Novartis
NYSENVS
47.45[46] 44.75[47] 49.11[48] 48.52[49] 49.41[50] 58.00[51] 57.36[52] 56.67[53] 58.57[54]
7 Increase 1 United States Merck & Co.
NYSEMRK
48 46.84[55] 42.30[56] 40.10[57] 39.80[58] 39.50[59] 42.24[60] 44.03[61] 47.27[62] 48.05[63]
8 Increase 1 United Kingdom GlaxoSmithKline
LSEGSK
43.92[64] 43.14[65] 42.05[66] 34.79[67] 29.84[68] 37.96[69] 41.61[70] 39.93[71] 41.39[72]
9 Increase 1 United States AbbVie
NYSEABBV
33.27[73] 32.75[74] 28.22[75] 25.56[76] 22.82[77] 19.96[78] 18.79[79]
10 Increase 1 France Sanofi
NYSESNY
39.28[80] 39.07[81] 42.91[82] 36.57[83] 36.73[84] 43.07[85] 42.08[86] 46.41[87] 44.34[88]
11 Increase 5 United States Bristol Myers Squibb
NasdaqBMY
26.15[89] 22.56[90] 20.80[91] 19.43[92] 16.56[93] 15.88[94] 16.39[95] 17.62[96] 21.24[97]
12 Decrease 1 United States Abbott Laboratories
NasdaqABT
31.90[98] 30.60[99] 27.39[100] 20.85[101] 20.41[102] 20.25[103] 21.85[104] 39.87[105] 38.85[106]
13 Increase 2 United States Thermo Fisher Scientific
NYSETMO
25.54[107] 24.36[107] 20.92[108] 18.27[109] 16.97[110] 16.89[111] 13.09[111] 12.51[112] 11.56[112]
14 Increase 2 United States 3M
NYSEMMM
28.7[107] 26.40[107] 24.23[113] 13.27[114] 22.37[115] 21.48[111] 20.09[111] 18.41[112] 17.32[112]
15 Decrease 2 Japan Takeda Pharmaceutical
TYO: 4502
31.17[116] 19.10[117] 16.70[118] 15.96[119] 14.93 16.84 17.36 18.91 17.80
16 Decrease 2 United States Medtronic
NYSEMDT
30.56[120] 29.95[121] 29.71[122] 20.94[123] 20.26[124] 17.01[125] 16.59[126] 16.18[127] 15.93[128]
17 Steady United Kingdom/Sweden AstraZeneca
LSEAZN
24.38[129] 22.09[130] 22.47[131] 23.00[132] 24.71[133] 26.10[134] 25.71[135] 27.97[136] 33.59[137]
18 Steady United States Amgen
NasdaqAMGN
23.40[138] 23.70[139] 22.80[140] 22.99[141] 21.66[142] 20.06[143] 18.68[144] 17.30[145] 15.58[146]
19 Steady United States Gilead Sciences
NasdaqGILD
22.45[147] 22.13[148] 25.70[149] 30.39[149] 32.15[149] 24.47[149] 10.80[149] 9.70[149] 8.39[149]
20 Steady United States Eli Lilly & Co
NYSELLY
22.32[150] 21.49[151] 22.90[152] 21.22[153] 20.00[154] 19.62[155] 23.11[156] 22.60[157] 24.29[158]
21 Increase 1 Germany Boehringer Ingelheim
Private
22.90[159] 21.67[160] 17.54[161] 16.41[161] 17.70[161] 18.68[161] 18.89[161] 18.34[161]
22 Increase 3 United States Danaher Corporation
NYSEDHR
17.91[162] 19.89[163] 18.33[164] 16.88[165] 20.56[166] 19.91[167] 19.12[168] 18.26[169] 16.09[170]
23 Increase 1 Germany Merck Group
ETR: MRK
18.25[171] 16.48[172] 18.70[173] 16.62[174] 14.25[175] 15.29[176] 14.73[173] 14.36[173] 14.31[173]
24 Decrease 1 Denmark Novo Nordisk
NYSENVO
18.30[177] 16.99[178] 18.77[179] 16.61[180] 16.06[181] 15.83[182] 14.88[183] 13.48[184] 11.56[185]
25 Steady United States Viatris
NasdaqVTRS
26 Decrease 4 United States GE Healthcare
Subsidiary of General Electric
19.94[186] 19.78[187] 19.02[188] 18.21[189] 17.64[190] 18.30[191] 18.20[192] 18.29[193]
27 Increase 1 Germany Siemens Healthineers
FWBSHL
16.29[194] 15.44[195] 16.56[196] 14.25[197] 14.06[198]
28 Increase 4 United States Medline Industries
Private
13.9[199] 11.7[200]
29 Decrease 2 United States Becton, Dickinson and Company
NYSEBDX
17.29[201] 15.98[202] 12.09[203] 12.48[204] 10.28[205] 8.45[206] 8.05[207] 7.71[208] 7.58[209]
30 Decrease 2 Israel/United States Teva Pharmaceutical Industries
NasdaqTEVA
16.89[210] 18.90[211] 22.40[212] 21.90[213] 20.00[214] 20.27[215] 20.31[216] 18.31[217] 16.12[218]
31 Increase 2 United States Cardinal Health(Medical) segment
11.55[219] 15.4[220] 15.9[220] 14.3[220] 12.3[220] 9.2[220] 8.82[221] 5.67[221] 5.54[221]
32 Decrease 1 United States Stryker Corporation
NYSESYK
14.88[222] 13.60[223] 12.44[223] 11.33[224] 9.95[224] 9.68[225] 9.02[225] 8.66[226] 8.31[226]
33 Increase 2 United States Labcorp
NYSELH
11.55[227] 11.33[220] 10.31[220] 9.55[220] 8.51[220] 6.01[220] 5.81[221] 5.67[221] 5.54[221]
34 Decrease 2 United States Biogen
NasdaqBIIB
14.38[228] 13.45[229] 12.30[230] 11.40[231] 10.80[232] 9.70[233] 6.90[234] 5.50[235] 5.00[236]
35 Increase 1 United States Baxter International
NYSEBAX
11.36[237] 11.13 [238] 10.56 [238] 10.16 [239] 9.97 [240] 10.72 [241] 14.97 [242] 14.19 [243] 13.89 [243]
36 Decrease 2 Japan Astellas Pharma
TYO: 4503
12.20[244] 12.27[245] 12.07 12.63 11.48 10.49 9.25 8.92 8.78
37 Steady United States IQVIA
NYSEIQV
11.09 [246] 10.41 [247] 9.70 [248] 5.36 [249] 4.33 [250] 4.17 [251] 3.81 [252] 3.69 [253]
38 Increase 1 United States Henry Schein
NasdaqHSIC
11.36[254] 11.13 [238] 10.11 [238] 11.16 [255] 8.97 [256] 8.72 [257] 7.97 [258] 6.19 [243] 6.89 [243]

See also[edit]

Notes[edit]

References[edit]

  1. ^ "Johnson & Johnson Reports 2019 Fourth-Quarter And Full Year Results: | BioSpace".
  2. ^ "Johnson & Johnson Reports 2018 Fourth-Quarter Results". Content Lab - U.S.
  3. ^ "Johnson & Johnson Reports 2017 Fourth-Quarter Results: - Johnson & Johnson". www.jnj.com.
  4. ^ "Johnson & Johnson Reports 2016 Fourth-Quarter Results - Johnson & Johnson". www.jnj.com.
  5. ^ "Johnson & Johnson Reports 2015 Fourth-Quarter Results". Archived from the original on 2016-02-11. Retrieved 2018-01-28.
  6. ^ "Johnson & Johnson Reports 2014 Fourth-Quarter and Full-Year Results - Johnson & Johnson". www.jnj.com.
  7. ^ "Johnson & Johnson Reports 2013 Fourth-Quarter and Full-Year Results - Johnson & Johnson". www.jnj.com.
  8. ^ "Johnson & Johnson Reports 2012 Fourth-Quarter and Full-Year Results".
  9. ^ "Johnson & Johnson Reports 2011 Fourth-Quarter and Full-Year Results".
  10. ^ http://ir.sinopharmgroup.com.cn/attachment/202004240816014279248723_en.pdf
  11. ^ http://ir.sinopharmgroup.com.cn/attachment/2019042506350100033473013_en.pdf
  12. ^ http://ir.sinopharmgroup.com.cn/attachment/2018042506320200033121116_en.pdf
  13. ^ http://ir.sinopharmgroup.com.cn/attachment/2017042106200200012785604_en.pdf
  14. ^ http://ir.sinopharmgroup.com.cn/attachment/201607131609541765679138_en.PDF
  15. ^ http://ir.sinopharmgroup.com.cn/attachment/2015041006320100032166702_en.pdf
  16. ^ http://ir.sinopharmgroup.com.cn/attachment/20140410061701001886801_en.pdf
  17. ^ http://ir.sinopharmgroup.com.cn/attachment/20130419164701001633683_en.pdf
  18. ^ http://ir.sinopharmgroup.com.cn/attachment/20120420064701001411060_en.pdf
  19. ^ https://www.roche.com/dam/jcr:e49f6995-e813-43c1-9302-c9b7d0bddbc8/en/irp200130-a.pdf
  20. ^ https://www.roche.com/dam/jcr:af865dfd-50fb-458b-9cac-34097db9d3ec/en/ar18e.pdf
  21. ^ "Roche reports good results in 2017". www.roche.com.
  22. ^ https://www.roche.com/dam/jcr:ee2f197f-5487-4629-9e28-66b77c9cbbab/en/ar16e.pdf
  23. ^ https://www.roche.com/dam/jcr:9b36e11d-495c-42f5-b757-e80c4e88d793/en/gb15e.pdf
  24. ^ https://www.roche.com/dam/jcr:880b44a1-3fd6-4e66-bf10-f4af1e724d4d/en/gb14e.pdf
  25. ^ https://www.roche.com/dam/jcr:64fd6b2d-1a76-467f-badd-ab94b85b6d70/en/gb13e.pdf
  26. ^ https://www.roche.com/dam/jcr:3e048249-e3ce-4969-a77e-cc90d8f3fa73/en/gb12e.pdf
  27. ^ https://www.roche.com/dam/jcr:52174b39-feab-4210-82f6-9b8786a69ecf/en/gb11e.pdf
  28. ^ "PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2019 RESULTS | BioSpace".
  29. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Quarterly/2018/q4/Q4-2018-PFE-Earnings-Release.pdf
  30. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Quarterly/2017/Q4_2017_PFE_Earnings_Release.pdf
  31. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2016/2016-financial-report.pdf
  32. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2015/2015_Pfizer_Financial_Report.pdf
  33. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2014/2014_Pfizer_Financial_Report.pdf
  34. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2013/FinancialReport2013.pdf
  35. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2012/financial2012.pdf
  36. ^ https://s21.q4cdn.com/317678438/files/doc_financials/Annual/2011/financial2011.pdf
  37. ^ "Bayer AG Annual Report 2019" (PDF). www.bayer.com.
  38. ^ "Bayer's Annual Report 2018". www.annualreport2018.bayer.com.
  39. ^ http://www.annualreport2017.bayer.com/servicepages/downloads/files/bayer_ar17_entire.pdf
  40. ^ http://www.annualreport2016.bayer.com/servicepages/downloads/files/bayer_ar16_entire.pdf
  41. ^ http://www.annualreport2015.bayer.com/servicepages/downloads/files/entire_bayer_ar15.pdf
  42. ^ AG, Bayer. "Bayer – Global Home". www.bayer.com.
  43. ^ https://www.bayer.com/en/ar-2013.pdfx
  44. ^ https://www.bayer.com/en/ar-2012.pdfx
  45. ^ https://www.bayer.com/en/ar-2011.pdfx
  46. ^ https://www.novartis.com/sites/www.novartis.com/files/q4-2019-media-release-en.pdf
  47. ^ https://www.novartis.com/sites/www.novartis.com/files/q4-2018-media-release-en.pdf
  48. ^ "Archived copy" (PDF). Archived from the original (PDF) on 2018-01-29. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  49. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2016-en.pdf
  50. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2015-en.pdf
  51. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2014-en.pdf
  52. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2013-en.pdf
  53. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2012-en.pdf
  54. ^ https://www.novartis.com/sites/www.novartis.com/files/novartis-annual-report-2011-en.pdf
  55. ^ "Merck Announces Fourth-Quarter and Full-Year 2019 Financial Results".
  56. ^ "Merck Announces Fourth-Quarter and Full-Year 2018 Financial Results". BioSpace.
  57. ^ LaVito, Angelica (2 February 2018). "Merck posts mixed fourth-quarter results as Keytruda sales skyrocket".
  58. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2017/Q4/merck-q4-10k.pdf
  59. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2015/annual/MRK_2015_Form_10-K_FINAL_r879.pdf
  60. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2014/annual/2014-Form-10-K_FINAL_022715.pdf
  61. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2013/annual/MRK_2013_Form_10_K_FINAL_022714.pdf
  62. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2012/annual/MRK_form_10_k_2012.pdf
  63. ^ http://s21.q4cdn.com/488056881/files/doc_financials/2011/annual/form-10-k-2011.pdf
  64. ^ https://www.gsk.com/media/5820/fy-2019-results-announcement.pdf
  65. ^ "GSK delivers sales, earnings and cash flow growth in 2018 - GSK". www.gsk.com.
  66. ^ https://www.gsk.com/media/4629/fy-2017-results-announcement.pdf
  67. ^ https://www.gsk.com/media/3609/annual-report-2016.pdf
  68. ^ https://www.gsk.com/media/2718/gsk-annual-report-2016.pdf
  69. ^ https://www.gsk.com/media/2710/gsk-annual-report-2014-interactive.pdf
  70. ^ https://www.gsk.com/media/2701/annual-report-2013-interactive.pdf
  71. ^ https://www.gsk.com/media/2694/annual-report-2012.pdf
  72. ^ https://www.gsk.com/media/2696/annual-report-2011.pdf
  73. ^ "AbbVie Reports Full-Year and Fourth-Quarter 2019 Financial Results".
  74. ^ "AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results - AbbVie News Center". news.abbvie.com.
  75. ^ "Financial Release - AbbVie". investors.abbvie.com.
  76. ^ "Financial Release - AbbVie". investors.abbvie.com.
  77. ^ "Financial Release - AbbVie". investors.abbvie.com.
  78. ^ "Financial Release - AbbVie". investors.abbvie.com.
  79. ^ "Financial Release - AbbVie". investors.abbvie.com.
  80. ^ https://www.sanofi.com/en/investors/financial-results-and-events/financial-results/Q4-results-2019
  81. ^ https://www.sanofi.com/-/media/Project/One-Sanofi-Web/Websites/Global/Sanofi-COM/Home/en/investors/docs/press-releases/Q42018results.pdf?la=en&hash=CDCE30350F0C658C000A909535AD9AF636A93560
  82. ^ https://www.sanofi.com/media/Project/One-Sanofi-Web/sanofi-com/en/investors/docs/press-releases/Press_release_Q4_FY_2017.pdf
  83. ^ https://en.sanofi.com/Images/49288_20-F_2016.pdf
  84. ^ https://en.sanofi.com/Images/45889_Sanofi_20-F_2015_V2.pdf
  85. ^ https://en.sanofi.com/Images/38473_Sanofi_20-F_2014.pdf
  86. ^ https://en.sanofi.com/Images/35795_20F_SANOFI_2013.pdf
  87. ^ https://en.sanofi.com/Images/31972_20-F_2012_V2.pdf
  88. ^ https://en.sanofi.com/Images/29804_20F_2011.pdf
  89. ^ https://www.biospace.com/article/releases/bristol-myers-squibb-reports-fourth-quarter-and-full-year-financial-results-for-2019/?s=79
  90. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results - BMS Newsroom". news.bms.com.
  91. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results". investors.bms.com.
  92. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2016 Financial Results - BMS Newsroom". news.bms.com.
  93. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2015 Financial Results - BMS Newsroom". news.bms.com.
  94. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2014 Financial Results - BMS Newsroom". news.bms.com.
  95. ^ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2013 Financial Results - BMS Newsroom". news.bms.com.
  96. ^ https://s21.q4cdn.com/104148044/files/doc_financials/annual_reports/Bristol-Myers-Squibb-2012AR-lr.pdf
  97. ^ https://s21.q4cdn.com/104148044/files/doc_financials/annual_reports/BristolMyersSquibb-2011-AnnualReport.pdf
  98. ^ https://www.biospace.com/article/releases/abbott-reports-fourth-quarter-2019-results-announces-strong-forecast-for-2020/?s=72
  99. ^ "Abbott Reports 2018 Results and Issues Strong Forecast for 2019". BioSpace.
  100. ^ Abbott. "Abbott Reports Fourth-Quarter 2017 Results". www.prnewswire.com.
  101. ^ Abbott. "Abbott Reports Fourth-Quarter 2016 Results". www.prnewswire.com.
  102. ^ "Abbott Reports Fourth-Quarter 2015 Results".
  103. ^ "Abbott Reports Fourth-Quarter 2014 Results".
  104. ^ Abbott. "Abbott Reports Fourth-Quarter and Full-Year 2013 Results". www.prnewswire.com.
  105. ^ "Abbott Reports Fourth-Quarter and Full-Year 2012 Results".
  106. ^ "Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2011 Earnings - FiercePharma". www.fiercepharma.com.
  107. ^ a b c d https://www.biospace.com/article/releases/thermo-fisher-scientific-reports-fourth-quarter-and-full-year-2019-results/?s=72
  108. ^ https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2018/Thermo-Fisher-Scientific-Reports-Fourth-Quarter-and-Full-Year-2017-Results/default.aspx
  109. ^ https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2017/Thermo-Fisher-Scientific-Reports-Fourth-Quarter-and-Full-Year-2016-Results/default.aspx
  110. ^ https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2016/Thermo-Fisher-Scientific-Reports-Record-Fourth-Quarter-and-Full-Year-2015-Results/default.aspx
  111. ^ a b c d https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2015/Thermo-Fisher-Scientific-Reports-Strong-Fourth-Quarter-and-Full-Year-2014-Results/default.aspx
  112. ^ a b c d http://thermofisher.mediaroom.com/2013-01-31-Thermo-Fisher-Scientific-Reports-Fourth-Quarter-and-Full-Year-2012-Results
  113. ^ https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2018/Thermo-Fisher-Scientific-Reports-Fourth-Quarter-and-Full-Year-2017-Results/default.aspx
  114. ^ https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2017/Thermo-Fisher-Scientific-Reports-Fourth-Quarter-and-Full-Year-2016-Results/default.aspx
  115. ^ https://ir.thermofisher.com/investors/news-and-events/news-releases/news-release-details/2016/Thermo-Fisher-Scientific-Reports-Record-Fourth-Quarter-and-Full-Year-2015-Results/default.aspx
  116. ^ https://www.takeda.com/newsroom/newsreleases/2020/takeda-accelerates-transformation-solid-fy2019-results-confidence-in-fy2020-growth-momentum/
  117. ^ https://www.takeda.com/newsroom/newsreleases/2019/takeda-reports-fy2018-full-year-results-and-issues-fy2019-guidance/
  118. ^ "Takeda reports FY2017 full year results and issues FY2018 guidance". www.takeda.com.
  119. ^ "Takeda Pharmaceutical Company Limited and its Subsidiaries Consolidated Financial Statements Under IFRSs and Independent Auditor's Report" (PDF).{{cite web}}: CS1 maint: url-status (link)
  120. ^ https://investorrelations.medtronic.com/static-files/da4767cb-a6c9-4716-801e-48a0a3155e1f
  121. ^ https://investorrelations.medtronic.com/static-files/262eb1cb-ed16-422c-b33c-d9f031105481
  122. ^ https://investorrelations.medtronic.com/static-files/b6508122-6f3b-473e-9638-8c8b8dc226a5
  123. ^ https://investorrelations.medtronic.com/static-files/5f89558e-dd8c-48ff-9645-a279cdd38460
  124. ^ https://investorrelations.medtronic.com/static-files/07b454a5-4517-402f-999e-e1db87ff991e
  125. ^ https://investorrelations.medtronic.com/static-files/bcc415af-20c5-4f19-9efa-9312bb36cf03
  126. ^ https://investorrelations.medtronic.com/static-files/91cd662f-ceb7-4442-8de5-43fbd51202f8
  127. ^ https://investorrelations.medtronic.com/static-files/35f7dd75-6583-4c3c-a731-b95fefbd9793
  128. ^ https://investorrelations.medtronic.com/static-files/7f6de2e5-cec2-47a2-b37e-980c66c7c478
  129. ^ https://www.astrazeneca.com/content/dam/az/PDF/2019/full-year/Full-year_and_Q4_2019_results_announcement.pdf
  130. ^ https://www.astrazeneca.com/content/dam/az/PDF/2018/full-year/Full-Year_2018_Results_announcement.pdf
  131. ^ https://www.astrazeneca.com/content/dam/az/PDF/2017/Full-Year/Full-Year%202017%20Results%20announcement%20.pdf
  132. ^ https://www.astrazeneca.com/content/dam/az/PDF/Full_year_and_q4_2016_results/Full_Year_and_Q4_2016_Results_announcement.pdf
  133. ^ "Full-Year and Q4 2015 Results". www.astrazeneca.com.
  134. ^ "AstraZeneca PLC fourth quarter and full year results 2014". www.astrazeneca.com.
  135. ^ "AstraZeneca PLC fourth quarter and full year results 2013 - AstraZeneca". www.astrazeneca.com.
  136. ^ "AstraZeneca PLC Fourth quarter and full year results 2012". www.astrazeneca.com.
  137. ^ "AstraZeneca PLC Fourth quarter and full year results 2011". www.astrazeneca.com.
  138. ^ https://www.biospace.com/article/releases/amgen-reports-fourth-quarter-and-full-year-2019-financial-results/?s=72
  139. ^ "Amgen - Investors - Press Release". investors.amgen.com.
  140. ^ "Amgen Reports Fourth Quarter And Full Year 2017 Financial Results". www.amgen.com.
  141. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjY1NTQ1fENoaWxkSUQ9MzczMzk1fFR5cGU9MQ==&t=1
  142. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NjI2OTYzfENoaWxkSUQ9MzI5ODc3fFR5cGU9MQ==&t=1
  143. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTc0NTMzfENoaWxkSUQ9Mjc3NjczfFR5cGU9MQ==&t=1
  144. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NTM3Nzc3fENoaWxkSUQ9MjI2ODE2fFR5cGU9MQ==&t=1
  145. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDk5NjQxfENoaWxkSUQ9NTM5NDU4fFR5cGU9MQ==&t=1
  146. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MTM0MzEzfENoaWxkSUQ9LTF8VHlwZT0z&t=1
  147. ^ https://www.biospace.com/article/releases/gilead-sciences-announces-fourth-quarter-and-full-year-2019-financial-results/?s=72
  148. ^ "Gilead Sciences Announces Fourth Quarter and Full Year 2018 Financial Results". BioSpace.
  149. ^ a b c d e f g "Investor Overview". Gilead Sciences.
  150. ^ https://www.biospace.com/article/releases/lilly-reports-strong-fourth-quarter-and-full-year-2019-financial-results-updates-2020-guidance-for-pending-dermira-acquisition/?s=72
  151. ^ "Lilly Reports Strong Fourth-Quarter and Full-Year 2018 Financial Results, Lowers 2019 EPS Guidance to Reflect the Pending Acquisition of Loxo Oncology". BioSpace.
  152. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x970018/15B962F7-AF5A-4FFA-BE13-42206D3A0820/Q4_2017_PressRelease.pdf
  153. ^ "Lilly Reports Fourth-Quarter and Full-Year 2016 Results (NYSE:LLY)". investor.lilly.com.
  154. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x871993/5BE670A3-2B82-4876-8471-CA6BC3BD49F8/Lilly_Q4_2015_Press_Release.pdf
  155. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x806120/8637C572-31C4-402E-A179-5E107A5366B2/Q414_Lilly_Sales_and_Earnings_Press_Release.pdf
  156. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x721860/2DB60538-94FE-4E96-98D2-DA72CC301EA0/Q413%20Lilly%20Sales%20and%20Earnings%20Press%20Release.pdf
  157. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x631117/85679233-E13C-4FE7-9431-E97EFFDA6D5D/Q412%20Lilly%20Sales%20and%20Earnings%20Press%20Release.pdf
  158. ^ http://files.shareholder.com/downloads/LLY/5951368162x0x538046/24A15621-7850-45EC-8E20-30535C3D9FC9/Q411_Lilly_Sales_and_Earnings_Press_Release.pdf
  159. ^ http://annualreport.boehringer-ingelheim.com/fileadmin/Download-Center/BI_GB_18_en_ohne_Unterschriften.pdf
  160. ^ www.boehringer-ingelheim.com https://www.boehringer-ingelheim.com/corporate-profile/our-company/financial-highlights. {{cite web}}: Missing or empty |title= (help)
  161. ^ a b c d e f "Boehringer Ingelheim total revenue 2007-2017 - Statistic". Statista.
  162. ^ http://investors.danaher.com/image/4Q2019+Danaher+Earnings+Presentation.pdf
  163. ^ http://investors.danaher.com/download/Danaher_Annual_Report_2018.pdf
  164. ^ http://investors.danaher.com/download/danaher_2017_annualreport.pdf
  165. ^ http://investors.danaher.com/download/Danaher_2016+Annual+Report.pdf
  166. ^ http://investors.danaher.com/download/2015+Danaher+Annual+Report.pdf
  167. ^ http://investors.danaher.com/download/DHR_AR_2014.pdf
  168. ^ http://investors.danaher.com/download/DHR_AR_2013.pdf
  169. ^ http://investors.danaher.com/download/DHR_AR_2012.pdf
  170. ^ http://investors.danaher.com/download/DHR_AR_2011.pdf
  171. ^ https://www.merckgroup.com/investors/reports-and-financials/earnings-materials/2019-q4/en/2019-Q4-Report-EN.pdf
  172. ^ "Q4/FY Results of 2018 - News - Merck KGaA, Darmstadt, Germany". www.emdgroup.com.
  173. ^ a b c d "404 page - EMD Group". www.emdgroup.com. {{cite web}}: Cite uses generic title (help)
  174. ^ http://ar2016.merckgroup.com/sites/default/files/downloads/en/merck_annual_report_2016.pdf
  175. ^ http://ar2015.emdgroup.com/sites/default/files/downloads/emd/Merck_GB2015_EN.pdf
  176. ^ http://ar2014.merckgroup.com/sites/default/files/downloads/en/Merck_GB2014_EN.pdf
  177. ^ https://www.novonordisk.com/content/dam/Denmark/HQ/investors/irmaterial/quarterly_financial_reports/2020/20200502_Financial%20statement%20Q4%202019_UK.pdf
  178. ^ https://www.novonordisk.com/content/dam/Denmark/HQ/investors/irmaterial/quarterly_financial_reports/2019/20190201_Financial%20statement%20Q4%202018_UK.pdf
  179. ^ "News details". www.novonordisk.com.
  180. ^ https://www.novonordisk.com/content/dam/Denmark/HQ/investors/irmaterial/quarterly_financial_reports/2017/20170202_Financial%20statement_FY%202016_UK.pdf
  181. ^ Transcripts, SA (3 February 2016). "Novo Nordisk's (NVO) CEO Lars Rebien Sorensen on Q4 2015 Results - Earnings Call Transcript".
  182. ^ Transcripts, SA (30 January 2015). "Novo Nordisk's (NVO) CEO Lars Sorensen on Q4 2014 Results - Earnings Call Transcript".
  183. ^ Transcripts, SA (31 January 2014). "Novo Nordisk A/S Management Discusses Q4 2013 Results - Earnings Call Transcript".
  184. ^ Transcripts, SA (31 January 2013). "Novo Nordisk's CEO Discusses Q4 2012 Results - Earnings Call Transcript".
  185. ^ http://www.novonordisk.co.uk/content/dam/Denmark/HQ/Commons/documents/Novo-Nordisk-AR-2011-en.pdf
  186. ^ "General Electric Healthcare segment revenue 2008-2020".
  187. ^ "General Electric Healthcare segment revenue 2008-2020".
  188. ^ "General Electric Healthcare segment revenue 2008-2020".
  189. ^ "General Electric Healthcare segment revenue 2008-2020".
  190. ^ "General Electric Healthcare segment revenue 2008-2020".
  191. ^ "General Electric Healthcare segment revenue 2008-2020".
  192. ^ "General Electric Healthcare segment revenue 2008-2020".
  193. ^ "General Electric Healthcare segment revenue 2008-2020".
  194. ^ https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/1800000006835562/12e08501046c/Siemens-Healthineers-Annual-Report-2019.pdf
  195. ^ https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/1800000005904947/ef806566e5ee/Annual-Report-2018.pdf
  196. ^ https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/1800000004856382/73e26777cfa3/Siemens_Healthineers_Combined_Financial_Statements_FY17-15_V2_.pdf
  197. ^ https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/1800000004856382/73e26777cfa3/Siemens_Healthineers_Combined_Financial_Statements_FY17-15_V2_.pdf
  198. ^ https://cdn0.scrvt.com/ec41840e14df52192984582863de63fa/1800000004856382/73e26777cfa3/Siemens_Healthineers_Combined_Financial_Statements_FY17-15_V2_.pdf
  199. ^ "Corporate Social Responsibility Report 2019".
  200. ^ https://www.medline.com/media/catalog/Docs/MKT/WP/CSR-2019.pdf
  201. ^ https://investors.bd.com/static-files/eb5a4eef-e5ef-4522-aa7b-1dfcb4df0443
  202. ^ https://investors.bd.com/static-files/eb5a4eef-e5ef-4522-aa7b-1dfcb4df0443
  203. ^ https://investors.bd.com/static-files/eb5a4eef-e5ef-4522-aa7b-1dfcb4df0443
  204. ^ https://investors.bd.com/static-files/eb5a4eef-e5ef-4522-aa7b-1dfcb4df0443
  205. ^ https://investors.bd.com/static-files/8cc141b1-2f6d-4cd4-8d24-faabe1f14b1e
  206. ^ https://investors.bd.com/static-files/8cc141b1-2f6d-4cd4-8d24-faabe1f14b1e
  207. ^ https://investors.bd.com/static-files/8cc141b1-2f6d-4cd4-8d24-faabe1f14b1e
  208. ^ https://investors.bd.com/static-files/8cc141b1-2f6d-4cd4-8d24-faabe1f14b1e
  209. ^ https://investors.bd.com/static-files/03dfef9f-a6e6-4d98-9b7f-39b5cee53055
  210. ^ "Teva Reports Fourth Quarter and Full Year 2019 Financial Results".
  211. ^ https://s24.q4cdn.com/720828402/files/doc_downloads/doc_financial/2018/q4/Teva-Form-10-K-2018.pdf
  212. ^ "Teva Reports 2017 Full Year and Fourth Quarter Financial Results". 8 February 2018.
  213. ^ http://www.tevapharm.com/news/teva_reports_full_year_and_fourth_quarter_2016_financial_results_02_17.aspx
  214. ^ http://www.tevapharm.com/news/teva_reports_full_year_2015_and_fourth_quarter_financial_results_02_16.aspx
  215. ^ "Teva Reports Fourth Quarter and Full Year 2014 Results". www.tevapharm.com.
  216. ^ http://www.tevapharm.com/news/teva_reports_fourth_quarter_and_full_year_2013_results_02_14.aspx
  217. ^ "Teva Reports Fourth Quarter and Full Year 2012 Results". tevapharm.com.
  218. ^ http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9MTI2NDkwfENoaWxkSUQ9LTF8VHlwZT0z&t=1
  219. ^ https://ir.labcorp.com/static-files/753d1464-9421-43f1-be83-d5e0be586800
  220. ^ a b c d e f g h i j "Overview | Laboratory Corporation of America Holdings".
  221. ^ a b c d e f "Overview | Laboratory Corporation of America Holdings".
  222. ^ "Stryker reports 2019 results and 2020 outlook".
  223. ^ a b https://s22.q4cdn.com/857738142/files/doc_financials/2018/Stryker_Annual_Report_2018.pdf
  224. ^ a b https://s22.q4cdn.com/857738142/files/doc_financials/2016/STRYKER-2016-AR.pdf
  225. ^ a b https://s22.q4cdn.com/857738142/files/doc_financials/2014/SYK_AR-14_4_29_15-FINAL.pdf
  226. ^ a b https://s22.q4cdn.com/857738142/files/doc_financials/2012/SYK-2012-AR_-03-14-13-FINAL_Single-Pages.pdf
  227. ^ https://ir.labcorp.com/static-files/753d1464-9421-43f1-be83-d5e0be586800
  228. ^ https://investors.biogen.com/static-files/ce31eed8-8862-4bec-a63f-77c0fd6e15a1
  229. ^ http://investors.biogen.com/static-files/c0d4fbe2-d4f2-404b-be17-19e770386d6e
  230. ^ "Biogen's Spinraza: Great Launch, Rough Ride". 25 January 2018 – via www.bloomberg.com.
  231. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/Biogen_Annual_Report_2016_on_Form_10K.pdf
  232. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/Biogen_Annual_Report_2015_on_Form_10K.pdf
  233. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/Biogen_2014_Annual_Report_Web.pdf
  234. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/BiogenIdec_AR_2013.pdf
  235. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/BiogenIdec_AR_2012.pdf
  236. ^ http://investors.biogen.com/sites/biogen.investorhq.businesswire.com/files/doc_library/file/2011ar.pdf
  237. ^ http://d18rn0p25nwr6d.cloudfront.net/CIK-0000010456/c8c941c6-2b54-474e-9ffd-e4be95a75a58.pdf
  238. ^ a b c d https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2018/q4/Q4-2018-BAX-FINANCIAL-SCHEDULES-(FINAL).pdf
  239. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2017/q4/Q4-2017-BAX-FINANCIAL-SCHEDULES-(FINAL).pdf
  240. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2016/q4/Q4-2016-Financial-Schedules.pdf
  241. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2015/q4/Q4-2015-Financial-Schedules.pdf
  242. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2014/q4/Q4-2014-FINAL-Financial-Schedules.pdf
  243. ^ a b c d https://s22.q4cdn.com/911189824/files/doc_downloads/financial_schedules/2012/Reclassified-Sales-Final.pdf
  244. ^ https://sw4503.swcms.net/en/ir-library/business-results/inframe/main/010/teaserItems1/00/linkList/0/link/4q2019_en_v1.pdf
  245. ^ "Astellas Pharma Inc. Annual Report 2018" (PDF). www.astellas.com.
  246. ^ https://s24.q4cdn.com/326377938/files/doc_financials/2019/annual/IQV-2019-10-K-Filed-(with-exhibits).pdf
  247. ^ https://s24.q4cdn.com/326377938/files/doc_financials/2019/annual/IQV-2019-10-K-Filed-(with-exhibits).pdf
  248. ^ https://s24.q4cdn.com/326377938/files/doc_financials/2019/annual/IQV-2019-10-K-Filed-(with-exhibits).pdf
  249. ^ https://s24.q4cdn.com/326377938/files/doc_financials/annual/iqvia/QuintilesIMS_2016_Annual-Report_Final-(1).pdf
  250. ^ https://s24.q4cdn.com/326377938/files/doc_financials/annual/iqvia/QuintilesIMS_2016_Annual-Report_Final-(1).pdf
  251. ^ https://s24.q4cdn.com/326377938/files/doc_financials/annual/iqvia/QuintilesIMS_2016_Annual-Report_Final-(1).pdf
  252. ^ https://s24.q4cdn.com/326377938/files/doc_financials/annual/iqvia/QuintilesIMS_2016_Annual-Report_Final-(1).pdf
  253. ^ https://s24.q4cdn.com/326377938/files/doc_financials/annual/iqvia/QuintilesIMS_2016_Annual-Report_Final-(1).pdf
  254. ^ http://d18rn0p25nwr6d.cloudfront.net/CIK-0000010456/c8c941c6-2b54-474e-9ffd-e4be95a75a58.pdf
  255. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2017/q4/Q4-2017-BAX-FINANCIAL-SCHEDULES-(FINAL).pdf
  256. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2016/q4/Q4-2016-Financial-Schedules.pdf
  257. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2015/q4/Q4-2015-Financial-Schedules.pdf
  258. ^ https://s22.q4cdn.com/911189824/files/doc_financials/quarterly/2014/q4/Q4-2014-FINAL-Financial-Schedules.pdf

External links[edit]